期刊文献+

ALDH^(hi)CD44^+细胞在乳腺癌组织中的表达及其与相关细胞信号传导通路之关系研究 被引量:2

Study on the expression of ALDHhiCD44^+ cells in breast cancer tissues and the association between ALDHhiCD44^+ cells and cell signal pathways
下载PDF
导出
摘要 目的:①探讨具有干细胞标记特性的ALDHhiCD44+细胞在乳腺癌组织及癌旁组织中的表达情况;②探讨乳腺癌MDA-MB-231细胞系中是否存在乳腺癌ALDHhiCD44+细胞亚群,并分析Wnt/β-catenin与Notch细胞信号通路中的重要基殷β-catenin和Notch1,在ALDHhiCD44+细胞亚群中的表达情况。方法:①试验组为30例乳腺癌患者的术中新鲜癌组织,另取19例癌旁2 cm组织标本作为对照;②机械-酶方法消化组织、收集细胞悬液,并行肿瘤细胞原代培养,再经流式细胞仪检测ALDH-hiCD44+细胞的含量;③流式细胞技术检测乳腺癌细胞系MDA-MB-231细胞中ALDHhiCD44+细胞的表达含量,并分选出AL-DHhiCD44+细胞,利用荧光定量RT-PCR技术检测ALDHhiCD44+细胞亚群和ALDHlow CD44+细胞亚群中β-catenin和Notch1的扩增情况。结果:①30例浸润性乳腺癌组织中有28例原代培养成功,19例癌旁组织中有15例能够培养出原代细胞。ALDH-hiCD44+细胞在癌组织原代培养的细胞中的含量为(3.85±2.59)%(0.86~8.00%),在癌旁组织原代细胞中含量为(0.13±0.07)%(0.05~0.19%),两值相比差异有统计学意义(P=0.035,P<0.05);②乳腺癌细胞系MDA-MB-231中,ALDHhiCD44+细胞含量为(0.82±0.067)%,且与ALDHlowCD44+细胞相比,ALDHhiCD44+细胞中β-catenin和Notch1的表达量是增高的(P<0.05)。结论:通过肿瘤组织原代细胞培养、检测新途径,进一步证实ALDHhiCD44+乳腺癌干细胞的存在,且其在癌灶的表达量高于癌旁组织。结合细胞系MDA-MB-231中的ALDHhiCD44+细胞检测,其中的β-catenin和Notch1表达增高,表明ALDH-hiCD44+细胞中Wnt/β-catenin和Notch细胞信号通路处于活化状态。 Objective ( 1 ) To explore the expression of stem cell markers characteristic ALDHhiCD44 + cells in breast cancer tissues and cancer adjacent tissues ; ( 2 ) To explore whether there was breast cancer stem cells ALDHhiCD44 ~ in breast ceneer cell line MDA - MB -231 and to analyze the gene amplification levels of the important genes 13 - catenin and Notchl in Wnt/β - eatenin and Notch signal pathways from ALDHhiCD44 * cells. Method ( I ) We collected the 30 eases of fresh cancer tissues during surgery as the experimental group and 19 cases of cancer adjacent tissue samples as control group; (2)We used the method of machinery - enzymes to digest the tis- sues for primary culture, and then the content of ALDHhiCD44 + cells were deteeted by flow eytometry; ( 3 ) ALDHhiCD44 + cells were studied in MDA- MB -231 cells by flow eytometry,the ALDHhiCD44+ cells and ALDHt~'CD44 ~ cells were separated by fluorescence - activated cell sorting, and the gene amplification of β- catenin and Notchl in Wnt and Notch signal pathways of ALDHhiCDd-4+ and AL- DHI~'CD44 ~ were also studied by real time polymerase chain reaction( real time PCR). Results (1) 28 out of 30 cases of invasive breast cancer tissues and 15 out of 19 cases of cancer adjacent tissues had been primary cultured successfully ,the average content of ALDHhiCD44 + cells in cancer tissues were (3.85 ± 2. 59) % (0. 86 ± 8.00% ) , in eancer adjacent tissues were( 0. 13 ±0. 07 )% (0.05± O. 19% ). The expression of ALDHhiCD44 + cells in cancer tissues was higher than the adjacent tissues (P =0. 035 ,P 〈0. 05). (2)The content of AL- DHhiCD44 + ceils was approximately( 0. 82± 0. 067 )% in MDA - MB -231 cells, the mRNA levels of 13 -eatenin and Noteh l were high- er in ALDHhiCD44 + cells than ALDHlowCD44+ cells( P 〈0. 05). Condusion We have uesd the method of the culture and detection of primary cells from breast cancer and cancer adjacent tissues to further confirmed the presence of breast cancer stem cells ALDHhiCD44 + , and the content of ALDHhiCD44 + cells were higher in the breast cancer tissues than cancer adjacent tissues ; the expression of 13 - eatenin and Notchl in ALDHhiCD44 + cells from MDA - MB - 231 cells were higher than ALDHlowCD44+ cells indieated that Wnt / β- caterfin and Notch cell signaling pathways in the ALDHhiCD44 + cells were activated.
出处 《吉林医学》 CAS 2013年第16期3077-3082,共6页 Jilin Medical Journal
基金 深圳市科技局项目[项目编号:201102010]
关键词 乳腺癌 肿瘤干细胞 信号传导通路 流式分选 Breast cancer Tumor stem cell Signaling pathway Huorescence - activated cell sorting
  • 相关文献

参考文献12

  • 1Bouras T,Pal B,Vaillant F,etal.Notch signaling regulatesmammary stem cell function and luminal cell-fate commitment[J].Cell stem cell,2008,3(4):429.
  • 2Thomas Schlange,Yutaka Matsuda,etal.Autocrine WNT sig-naling contributes to breast cancer cell proliferation via the canoni-cal WNT pathway and EGFR transactivation[J].Breast Cancer Re-search,2007,9(5):R63.
  • 3Emmanuelle Charafe-Jauffret,Christophe Ginestier,FloraIovino,etal.Breast cancer cell lines contain functional cancer stemcells with metastatic capacity and a distinct molecular signature[J].Cancer Res,2009,69(4):1302.
  • 4Tanei T,Morimoto K,Shimazu K,etal.Association of breastcancer stem cells identified by aldehyde dehydrogenase 1-expres-sion with resistance to sequential Paclitaxel and epirubicin basedchemotherapy for breast cancers[J].Clin cancer Res,2009,5(12):4234.
  • 5Heerma van Voss MR,van der Groep P,Bart J,etal.Expression of the stem cell marker ALDH1 in BRCA1 relatedbreast cancer[J].Cellular Onc,2011,34(1):3.
  • 6Yoshioka T,Umekita Y,Ohi Y,etal.Aldehyde dehydrogen-ase 1 expression is a predictor of poor prognosis in node-positivebreast cancers:a long-term follow-up study[J].Histopathology,2011,58(4):608.
  • 7韦伟,李朋,聂李平,胡慧,韩彬,于志强.乳腺癌组织CD44^+CD24^-/low细胞含量检测及其临床意义[J].中华实验外科杂志,2010(6):711-713. 被引量:2
  • 8郭呈芳,林丽芬,李朋,韦伟.乳腺癌患者外周血ALDH1^(high)CD44^+CD24^(-/low)细胞含量变化及其临床意义[J].中国妇幼保健,2012,27(26):4121-4123. 被引量:2
  • 9AlyshaK.Croker,Alison L.Allan.Inhibition of aldehyde de-hydrogenase(ALDH)activity reduces chemotherapy and radiationresistance of stem-like ALDHhiCD44+human breast cancer cells[J].Breast Cancer Research and Treatment,2012,133(1):75.
  • 10Bruni CA,Lynch CC,Rosa RR,et al.MMP-2contributesto the development of the mouse ventral prostate by impacting epi-thelial growth and morphogenesis[J].Dev Dyn,2010,239:2386.

二级参考文献9

  • 1Al -hajj M, Wicha MS, Benito -Hernandez A et al. Prospec- tive identification of tumorigenic breast cancer cells [ J]. Proc Natl Acad Sci USA, 2003, 100 (7) : 3983.
  • 2Ginestier C, Hurm H, Charafe - Jauffret E et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome [ J] . Cell Stem Cell, 2007, 1 (5): 555.
  • 3Croker A, Goodale D, Chu J et al. High aldehyde dehydrogen- ase and expression of cancer stem cell markers selects for breast cancer cancer cells with cells with enhanced malignant and metastatic ability [ J]. J Cell Mol Med, 2009, 13 (SB) : 2236.
  • 4Panayiotis A, Theodoropoulos, Hara Polioudaki et al. Circula- ting tumor cells with a putative stem cell phenotype in peripher- al blood of patients with breast cancer [ J]. Cancer Letter, 2009, 6 (27) : 485.
  • 5Bahriye Aktas, Mitra Tewes, Tanja Fehm et al. Stem cell and epithelial mesenchymal transition markers are frequently over- expressed in circulating tumor cells of metastatic breast cancer patients (J]. Clinical Cancer Res, 2009, 11 (46) : 920.
  • 6Reuben JM, Lee BN, Gao H et al. Primary breast cancer pa- tients with high percentages of bone marrow epithelial ceils with ALDH activity and CD44 + CD24-/low cancer stem cell pheno- type [J]. Eur J Cancer, 2011, 2 (18) : 1315.
  • 7刘春萍,熊一全,明洁,黄韬.CD326在乳腺癌细胞系的表达及其与乳腺癌细胞耐药的关系[J].中华实验外科杂志,2008,25(9):1155-1157. 被引量:3
  • 8LING Li-jun,WANG Shui,LIU Xiao-an,SHEN En-chao,DING Qiang,LU Chao,XU Jian,CAO Qin-hong,ZHU Hai-qing,WANG Feng.A novel mouse model of human breast cancer stem-like cells with high CD44^+CD24^–/lower phenotype metastasis to human bone[J].Chinese Medical Journal,2008(20):1980-1986. 被引量:10
  • 9叶志强,胡孝渠,黄卡特,万丽,谷甸娜,张筱骅.CD44^+/CD24^-/low在乳腺癌中表达及其临床意义[J].中华实验外科杂志,2009,26(4):436-438. 被引量:3

共引文献2

同被引文献46

  • 1马林,SEROVA Maria,PODGORNIAK Marie Pierre,BERTHOIS Yolande,MOURAH Samia,CALVO Fabien.双调蛋白反义核酸表达对裸鼠乳腺癌血管生成的抑制作用[J].中华肿瘤杂志,2005,27(9):521-523. 被引量:3
  • 2Croker A, Goodale D, Chu J, et al. High aldehyde dehydro- genase and extression of Cancer stem cell markers selects for breast cancer cells with cells with enhanced malignant and me-tastatic ability [J3 .Cell Mol Med, 2009, 13 (8B): 2236 - 2252.
  • 3Mylona E, Giannopoulou I, Fasomytakis E, et al. The clinico- pathologic and prognostic significance of CD44 +/CD24+/low and CD44 +/CD24+ tumor cells in invasive breast carcinomas [J3 . Hum Pathol, 2008, 7 (39) : 1096- 1102.
  • 4Nalwoga H, Ames JB, Wabinga H, et al. Expression of alde- hyde dehydrogenase 1 (ALDH1) is associated with basal - like markers and features of aggressive tumours in African breast cancer [J3 .Br J Cancer, 2010, 102 (2): 369 - 375.
  • 5Ginestier C, Hur MH, Charge -Jauffret E, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome J . Cell Stem Cell, 2007, 1 (5): 555-567.
  • 6Yoshioka T, Umekita Y, Ohi Y, et al. Aldehyde dehydrogen- ase 1 expression is a predictor of poor prognosis in node - posi- tive breast cancers: a long -term follow -up study [ J3 . His- topathology, 2011, 58 (4): 608-616.
  • 7Idowu MO, Kmieeiak M, Dumur C, et al. CD44 ( + ) / CD24 (-/low) cancer stem/progenitor cells are more abun- dant in triple - negative invasive breast carcinoma phenotype and are associated with poor outcome I J 1 . Hum Pathol, 2012, 3 (43): 364-373.
  • 8Kim H J, Kim M J, Ahn SH, et al. Different prognostic signif- icance of CD24 and CD44 expression in breast cancer according to hormone receptor status Jl Breast, 2011, 1 (20) : 78 - 85.
  • 9Morimoto K, Kim SJ, Tanei T, et al. Stem cell marker alde- hyde dehydrogenase 1 - positive breast cancers are character- ized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression [ J 3 . Cancer Sei, 2009, 100 (6) : 1062 - 1068.
  • 10Charge -Jauffret E, Ginestier C, Iovino F, et al. Aldehyde dehydrogenase 1 -positive cancer stem cells mediate metasta- sis and poor clinical outcome in inflammatory breast cancer J] . Clin Cancer Res, 2010, 16 (1) : 45 -55.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部